Indeed, recent studies have found that certain GLP-1 analogue therapies confer cardiovascular benefits to people with diabetes, which has high clinical importance given the prevalence of the cardiovascular comorbidity of diabetes10. Here, GLP1R is linked to diabetes mellitus.